322 related articles for article (PubMed ID: 31801452)
1. Targeted Biomedical Treatment for Autism Spectrum Disorders.
Pacheva I; Ivanov I
Curr Pharm Des; 2019; 25(41):4430-4453. PubMed ID: 31801452
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and Mitochondrial Dysfunction in Autism Spectrum Disorder.
Gevezova M; Sarafian V; Anderson G; Maes M
CNS Neurol Disord Drug Targets; 2020; 19(5):320-333. PubMed ID: 32600237
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of mitochondrial dysfunction in autism spectrum disorder: A systematic review and meta-analysis.
Frye RE; Rincon N; McCarty PJ; Brister D; Scheck AC; Rossignol DA
Neurobiol Dis; 2024 Jul; 197():106520. PubMed ID: 38703861
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder.
Rose S; Niyazov DM; Rossignol DA; Goldenthal M; Kahler SG; Frye RE
Mol Diagn Ther; 2018 Oct; 22(5):571-593. PubMed ID: 30039193
[TBL] [Abstract][Full Text] [Related]
5. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures.
Rossignol DA; Frye RE
Mol Psychiatry; 2012 Apr; 17(4):389-401. PubMed ID: 22143005
[TBL] [Abstract][Full Text] [Related]
6. Gut-Amygdala Interactions in Autism Spectrum Disorders: Developmental Roles via regulating Mitochondria, Exosomes, Immunity and microRNAs.
Seo M; Anderson G
Curr Pharm Des; 2019; 25(41):4344-4356. PubMed ID: 31692435
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial Dysfunction in Autism Spectrum Disorder: Unique Abnormalities and Targeted Treatments.
Frye RE
Semin Pediatr Neurol; 2020 Oct; 35():100829. PubMed ID: 32892956
[TBL] [Abstract][Full Text] [Related]
8. The Putative Role of Environmental Mercury in the Pathogenesis and Pathophysiology of Autism Spectrum Disorders and Subtypes.
Morris G; Puri BK; Frye RE; Maes M
Mol Neurobiol; 2018 Jun; 55(6):4834-4856. PubMed ID: 28733900
[TBL] [Abstract][Full Text] [Related]
9. Folate metabolism abnormalities in autism: potential biomarkers.
Frye RE; Slattery JC; Quadros EV
Biomark Med; 2017 Aug; 11(8):687-699. PubMed ID: 28770615
[TBL] [Abstract][Full Text] [Related]
10. Novel biomarkers of metabolic dysfunction is autism spectrum disorder: potential for biological diagnostic markers.
Khemakhem AM; Frye RE; El-Ansary A; Al-Ayadhi L; Bacha AB
Metab Brain Dis; 2017 Dec; 32(6):1983-1997. PubMed ID: 28831647
[TBL] [Abstract][Full Text] [Related]
11. Biomarker-Guided Strategy for Treatment of Autism Spectrum Disorder (ASD).
Liu H; Talalay P; Fahey JW
CNS Neurol Disord Drug Targets; 2016; 15(5):602-13. PubMed ID: 27071792
[TBL] [Abstract][Full Text] [Related]
12. Autism spectrum disorder (ASD) - biomarkers of oxidative stress and methylation and transsulfuration cycle.
Waligóra A; Waligóra S; Kozarska M; Damasiewicz-Bodzek A; Gorczyca P; Tyrpień-Golder K
Psychiatr Pol; 2019 Aug; 53(4):771-788. PubMed ID: 31760409
[TBL] [Abstract][Full Text] [Related]
13. [Epigenetics' implication in autism spectrum disorders: A review].
Hamza M; Halayem S; Mrad R; Bourgou S; Charfi F; Belhadj A
Encephale; 2017 Aug; 43(4):374-381. PubMed ID: 27692350
[TBL] [Abstract][Full Text] [Related]
14. DNA Methylation Associated with Mitochondrial Dysfunction in a South African Autism Spectrum Disorder Cohort.
Stathopoulos S; Gaujoux R; Lindeque Z; Mahony C; Van Der Colff R; Van Der Westhuizen F; O'Ryan C
Autism Res; 2020 Jul; 13(7):1079-1093. PubMed ID: 32490597
[TBL] [Abstract][Full Text] [Related]
15. Identification of likely associations between cerebral folate deficiency and complex genetic- and metabolic pathogenesis of autism spectrum disorders by utilization of a pilot interaction modeling approach.
Krsička D; Geryk J; Vlčková M; Havlovicová M; Macek M; Pourová R
Autism Res; 2017 Aug; 10(8):1424-1435. PubMed ID: 28339176
[TBL] [Abstract][Full Text] [Related]
16. Emerging biomarkers in autism spectrum disorder: a systematic review.
Frye RE; Vassall S; Kaur G; Lewis C; Karim M; Rossignol D
Ann Transl Med; 2019 Dec; 7(23):792. PubMed ID: 32042808
[TBL] [Abstract][Full Text] [Related]
17. Amino Acid Dysregulation Metabotypes: Potential Biomarkers for Diagnosis and Individualized Treatment for Subtypes of Autism Spectrum Disorder.
Smith AM; King JJ; West PR; Ludwig MA; Donley ELR; Burrier RE; Amaral DG
Biol Psychiatry; 2019 Feb; 85(4):345-354. PubMed ID: 30446206
[TBL] [Abstract][Full Text] [Related]
18. Metabolic pathology of autism in relation to redox metabolism.
Frye RE; James SJ
Biomark Med; 2014; 8(3):321-30. PubMed ID: 24712422
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial Dysfunction and Its Relationship with mTOR Signaling and Oxidative Damage in Autism Spectrum Disorders.
Yui K; Sato A; Imataka G
Mini Rev Med Chem; 2015; 15(5):373-89. PubMed ID: 25910652
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of Circadian Rhythms in Autism Spectrum Disorders.
Pinato L; Galina Spilla CS; Markus RP; da Silveira Cruz-Machado S
Curr Pharm Des; 2019; 25(41):4379-4393. PubMed ID: 31682208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
